Schellens JHM - Search Results

1

A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.

van Brummelen EMJ, Levchenko E, Dómine M, Fennell DA, Kindler HL, Viteri S, Gadgeel S, López PG, Kostorov V, Morgensztern D, Orlov S, Zauderer MG, Vansteenkiste JF, Baker-Neblett K, Vasquez J, Wang X, Bellovin DI, Schellens JHM, Yan L, Mitrica I, DeYoung MP, Trigo J. van Brummelen EMJ, et al. Among authors: schellens jhm. Invest New Drugs. 2020 Apr;38(2):457-467. doi: 10.1007/s10637-019-00783-7. Epub 2019 May 7. Invest New Drugs. 2020. PMID: 31065954 Free PMC article. Clinical Trial.

2

A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.

Planting A, Kho S, van der Burg M, Goey H, Schellens J, van den Bent M, van der Gaast A, de Boer-Dennert M, Stoter G, Verweij J. Planting A, et al. Cancer Chemother Pharmacol. 1997;40(4):347-52. doi: 10.1007/s002800050668. Cancer Chemother Pharmacol. 1997. PMID: 9225954 Free article. Clinical Trial.

3

Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel-cisplatin-topotecan in a phase I study.

Schoemaker NE, Herben VM, de Jong LA, van Waardenburg RC, Pluim D, ten Bokkel Huinink WW, Beijnen JH, Schellens JH. Schoemaker NE, et al. Anticancer Drugs. 2002 Jan;13(1):87-91. doi: 10.1097/00001813-200201000-00010. Anticancer Drugs. 2002. PMID: 11914645

4

Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.

Kruijtzer CM, Schellens JH, Mezger J, Scheulen ME, Keilholz U, Beijnen JH, Rosing H, Mathôt RA, Marcus S, van Tinteren H, Baas P. Kruijtzer CM, et al. J Clin Oncol. 2002 Dec 1;20(23):4508-16. doi: 10.1200/JCO.2002.04.058. J Clin Oncol. 2002. PMID: 12454106 Clinical Trial.

5

Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.

Bardelmeijer HA, Ouwehand M, Beijnen JH, Schellens JH, van Tellingen O. Bardelmeijer HA, et al. Invest New Drugs. 2004 Aug;22(3):219-29. doi: 10.1023/B:DRUG.0000026248.45084.21. Invest New Drugs. 2004. PMID: 15122069

6

Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam.

van Kesteren C, Zandvliet AS, Karlsson MO, Mathôt RA, Punt CJ, Armand JP, Raymond E, Huitema AD, Dittrich C, Dumez H, Roché HH, Droz JP, Ravic M, Yule SM, Wanders J, Beijnen JH, Fumoleau P, Schellens JH. van Kesteren C, et al. Invest New Drugs. 2005 Jun;23(3):225-34. doi: 10.1007/s10637-005-6730-3. Invest New Drugs. 2005. PMID: 15868378

7

Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid.

Vink SR, Schellens JH, van Blitterswijk WJ, Verheij M. Vink SR, et al. Invest New Drugs. 2005 Aug;23(4):279-86. doi: 10.1007/s10637-005-1436-0. Invest New Drugs. 2005. PMID: 16012787

8

Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.

Rademaker-Lakhai JM, Crul M, Pluim D, Sparidans RW, Baas P, Beijnen JH, van Zandwijk N, Schellens JH. Rademaker-Lakhai JM, et al. Anticancer Drugs. 2005 Oct;16(9):1029-36. doi: 10.1097/01.cad.0000176507.78928.4d. Anticancer Drugs. 2005. PMID: 16162981 Clinical Trial.

9

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours.

Siegel-Lakhai WS, Crul M, Zhang S, Sparidans RW, Pluim D, Howes A, Solanki B, Beijnen JH, Schellens JH. Siegel-Lakhai WS, et al. Br J Cancer. 2005 Nov 28;93(11):1222-9. doi: 10.1038/sj.bjc.6602850. Br J Cancer. 2005. PMID: 16251868 Free PMC article. Clinical Trial.

10

Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.

Kuppens IE, Witteveen PO, Schot M, Schuessler VM, Daehling A, Beijnen JH, Voest EE, Schellens JH. Kuppens IE, et al. Invest New Drugs. 2007 Jun;25(3):227-35. doi: 10.1007/s10637-006-9027-2. Epub 2006 Dec 5. Invest New Drugs. 2007. PMID: 17146730 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

754 results

Search Page

Filters